Trials / Completed
CompletedNCT00157963
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
A 12 Week, Open, Randomized, Parallel, Multicenter Study of Efficacy, Tolerability & Safety of Hydrochlorothiazide (+) Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
An efficacy and safety study of hydrochlorothiazide (+) losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks |
Timeline
- Start date
- 2005-02-05
- Primary completion
- 2006-02-08
- Completion
- 2006-02-08
- First posted
- 2005-09-12
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00157963. Inclusion in this directory is not an endorsement.